Tag: Gene Therapy
PharmaSignal — Gene Therapy
FDA clears first genetic hearing loss gene therapy
April 24, 2026
Pharmaphorum
Regeneron’s Otarmeni is the first gene therapy for congenital hearing loss to be cleared by the FDA, and will be made available for free in the US.
FDA approves Regeneron’s hearing loss gene therapy
April 23, 2026
BioPharma Dive
Otarmeni, now cleared to treat a rare, inherited kind of hearing loss, is the first gene therapy cleared under the FDA s national priority voucher program and will be offered to eligible patients at n